Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous dexamethasone for prevention of laryngeal mask airway complications in inguinal surgery
IRCT20200730048255N1Phase 3Completed
- Sponsor
- Ardabil University of Medical Sciences
- Start
- Aug 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexamethasone in postoperative nausea and vomiting (PONV), Post-extubation sore throat (POST), cough and 3 more (2 arms), sponsored by Ardabil University of Medical Sciences. Primary endpoints: Nausea and vomiting, Cough and 5 more. Started Aug 2020; status: completed.
02
Drugs
dexamethasone
03
Conditions
postoperative nausea and vomiting (PONV)Post-extubation sore throat (POST)coughpostanesthetic shivering (PAS)Dyspnoea (SOB)
Beyond the preview
Go deeper on IRCT20200730048255N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200730048255N1.